American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
52.79
-0.24 (-0.45%)
Mar 18, 2026, 10:53 AM EDT - Market open
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 11 analysts that cover American Healthcare REIT stock have a consensus rating of "Buy" and an average price target of $53.09, which forecasts a 0.57% increase in the stock price over the next year. The lowest target is $37 and the highest is $60.
Price Target: $53.09 (+0.57%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $52 → $57 | Strong Buy | Maintains | $52 → $57 | +7.97% | Mar 13, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $55 → $59 | Buy | Maintains | $55 → $59 | +11.76% | Mar 11, 2026 |
| Citigroup | Citigroup | Hold Maintains $52 → $55 | Hold | Maintains | $52 → $55 | +4.19% | Mar 2, 2026 |
| Citizens | Citizens | Buy Reiterates $60 | Buy | Reiterates | $60 | +13.66% | Feb 5, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $55 | Buy | Initiates | $55 | +4.19% | Jan 29, 2026 |
Financial Forecast
Revenue This Year
2.66B
from 2.26B
Increased by 17.93%
Revenue Next Year
2.96B
from 2.66B
Increased by 10.97%
EPS This Year
0.73
from 0.42
Increased by 74.80%
EPS Next Year
1.20
from 0.73
Increased by 63.81%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.7B | 3.9B | |||
| Avg | 2.7B | 3.0B | |||
| Low | 2.3B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.3% | 47.8% | |||
| Avg | 17.9% | 11.0% | |||
| Low | 0.0% | -11.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.83 | 2.42 | |
| Avg | 0.73 | 1.20 | |
| Low | 0.57 | 0.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 98.3% | 230.3% | |
| Avg | 74.8% | 63.8% | |
| Low | 35.9% | -6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.